Treatment of Idiopathic Pulmonary Fibrosis.
Grand Strand Medical Center
future management, ipf, literature review of disease, progressive interstitial lung disease, pulmonary disease
Internal Medicine | Respiratory Tract Diseases
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia of unknown cause, occurring in adults and limited to the lungs. In the past, treatment was aimed at minimizing inflammation and slowing the progression of inflammation to fibrosis. However, the underlying lesion in IPF may be more fibrotic than inflammatory, explaining why few patients respond to anti-inflammatory therapies and the prognosis remains poor. In this review of literature, we will be focusing on main lines of treatment including current medications, supportive care, lung transplantation evaluation, and potential future strategies of treatment.
Publisher or Conference
Abuserewa ST, Duff R, Becker G. Treatment of Idiopathic Pulmonary Fibrosis. Cureus. 2021;13(5):e15360. Published 2021 May 31. doi:10.7759/cureus.15360